NCT01343732View on ClinicalTrials.gov

Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Obsessive Compulsive Disorder
Interventions
DEVICE

Deep TMS

deep transcranial magnetic stimulation

Trial Locations (1)

Unknown

RECRUITING

Sheba Medical Center, Ramat Gan

Sponsors

Lead Sponsor

Brainsway
All Listed Sponsors
lead

Brainsway

INDUSTRY

NCT01343732 - Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects | Biotech Hunter | Biotech Hunter